| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Climb Bio, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 04 Jun 2025 | Direct | ||
| Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 3,000 | 18 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | 18 Dec 2025 | 1 | $0 | 4 | Director | 19 Dec 2025, 18:14 |
| VOR | Vor Biopharma Inc. | 18 Dec 2025 | 0 | $0 | 3 | Director | 19 Dec 2025, 18:04 |
| CLYM | Climb Bio, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:10 |
| ELYM | Eliem Therapeutics, Inc. | 26 Jun 2024 | 1 | $0 | 4 | Executive Chairman, Director | 28 Jun 2024, 18:09 |
| ELYM | Eliem Therapeutics, Inc. | 18 May 2023 | 1 | $0 | 4 | Executive Chairman, Director | 22 May 2023, 17:02 |
| ELYM | Eliem Therapeutics, Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 01 Jun 2022, 17:07 |
| ELYM | Eliem Therapeutics, Inc. | 09 Aug 2021 | 1 | $0 | 4 | Director | 11 Aug 2021, 17:14 |
| ELYM | Eliem Therapeutics, Inc. | 09 Aug 2021 | 0 | $0 | 3 | Director | 09 Aug 2021, 18:16 |